stem cells ROSE Flashcards

1
Q

what is a mesenchymal stem cell

A

small spindle-shaped cells with large nuclei, prominent nucleoli and fine chromatin. These are multipotent stem cells that differentiate as progenitor cells for all types of connective tissue, such as fibroblasts, osteoblasts, chondroblasts and preadipocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

where can mesenchymal stem cells be isolated from

A

bone marrow, adipose tissue, cord blood, amniotic fluid, iPSC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where may there be discrepancies in the study of the use of mesenchymal stem cells for clinical use

A

in in vitro vs in vivo studies there may be differences in the immune compatibility, dosing, fitness of culture adapted MSCs (how good are they at the point of delivery)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the 3 main modes of action of MSCs

A

differentiation, Paracrine effects, cell-cell effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe in detail how MSCs have paracrine effects

A

they may release signalling molecules such as cytokines, growth factors, extracellular vesicles. These effect neighboring cells. This can have an anti-inflammatory effect pro-regentive (release of growth factors) and make the immune system less aggressive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe how MSCs have cell-cell effects

A

they can interact with other cells through gap junctions between cells, tunneling nanotubes and surface molecule interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the main cell types MSCs can differentiate into

A

osteoblasts (bone cells)
Chondrocytes (cartaliage cells)
adipocytes (fat cells)
- important for tissue repair and regeneration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is a key application of mesenchymal stem cells

A

tissue repair and regeneration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is effereocytosis

A

the effective clearance of apoptotic cells by professional and non professional phagocytes. cellular clean-up where immune cells “eat” dying cells before they burst and cause inflammation. This process is boosted by MSCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

why is efferocytosis important

A
  • Prevents inflammation - Dead cells release toxic stuff if not cleaned up quickly. Efferocytosis prevents that.
  • Promotes healing - After gobbling up dying cells, macrophages release anti-inflammatory and pro-healing signals.
  • Controls immune responses - Helps calm the immune system after an injury or infection.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the reticuloendothelial system

A

The Reticuloendothelial System (RES) — sometimes called the mononuclear phagocyte system (MPS) — is a network of immune cells in your body that trap, engulf, and break down unwanted stuff like:
* Dead cells
* Microbes (like bacteria and viruses)
* Foreign particles (like nanoparticles or old drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the difference between the reticuloendothelial system and efferocytosis

A

efferocystosis is a specific process involving only apoptotic cells whereas RES involves a network of cells such as macrophages, kupffer cells etc to clear many dead things like cells and particles, essentially anything ‘unwanted’

RES is a full defence and cleaning network whereas effereocytosis is specialised to just apoptotic cells or dying cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how do MSCs have an anti-inflammatory effect

A

How MSCs effect efferocytosis
- They boost this
- They release inflammatory mediators, such as cytokines, that signal macrophages to eat dead/dying cells.
- They also reprogram macrophages (M1–>M2) to make them more efficient at efferocytosis
The removal of dead/dying cells prevents the release of toxins and upon engulfing and digesting these dead/dying cells, macrophages release anti-inflammatory signals. This helps calm the immune system following impairment by injury or infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is a somatic cell

A

any cell that is not a gamete, germ or stem cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is involved in somatic cell therapy meds

A

contains cells or tissues that have been manipulated to change their biological characteristics - their function is now different from its usual body function. they can be used to cure, diagnose and prevent disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is HOLOCLAR

A

Limbal stem cells are extracted from a patients healthy eye and cultured and grown in the lab. They are then trasnplanted into the same patients damaged eye where there is a diseased cornea resulting in loss of vision

17
Q

what is the link between holoclones, meroclones, paraclones and stratified epithelial cells

A

holoclones GIVE RISE TO meroclones GIVE RISE TO paraclones GIVE RISE TO stratified epithelium
as we progress, each cell type is less able to prliferate

18
Q

which has the highest proliferation ability: holoclones or meroclones

A

holoclones

19
Q

what is p63 in terms of holoclones

A

this is a transcription factor. High levels of its expression indicate the cell’s high ability to proliferate. Its levels are highest in holoclones and the levels decrease as cells give rise to other cells

20
Q

how are holoclones that can be used in HOLOCLAR therapy identified

A

using p63 marker

21
Q

where are holoclones mainly expressed

22
Q

what is cell tourism?

A

Stem cell tourism is a subset of the medical tourism industry. It involves patients traveling to another country to receive stem cell therapies that may not be available, affordable, or timely in their home country. Stem cell tourism is a form of medical tourism that is advertised to the public as a proven cure. It exists chiefly because most stem cell “treatments” are unproven and not readily available from reputable local medical services.

23
Q

why is stem cell torusim potentially dangerous

A

unproven and untested stem cells can result in injury or death

24
Q

what defines an unproven cell therapy

A

unclear scientific rationale, lack of understanding of MOA, insurrient in vitro data, lack of SOP for safe handling and management, inadequate information disclosed to patients to obtain informed consent, non-standardised methods

25
Q

what are the three main obstacles to cell therapies

A

setting up reliable consistent and scalable manufaturing system

cost effectiveness

ensuring therpies are safe and adequately regulated as well as ensuring the HCP knows how to use them

26
Q

What is an ATMP

A

An advanced therapy medicinal product (ATMP) is a medicinal product which is either:

a gene therapy medicinal product
a somatic cell therapy medicinal product
a tissue engineered product

27
Q

What does a MA ensure

A

quality, safety and efficay of all medicinal products

28
Q

why might current regulatory frameworks be slowing progress of cell based therapeutic and why might this be a problem

A

they have been called outdated and fragmented. They time for the product to reach the market is slow and costly so it is argued that this is reducing their clinical impact. It can result in people finding loopholes to receive treatment and therefore cell tourism and receiving unproven therapies.

29
Q

what are some key consierations around the regulation of these medicines

A

pharmacovigilence: detection, assessment, and undertanding to prevent adverse effects following market authorisation

good clinical practice: clinical trials to prove safety and efficacy, well defined scientific quality standards for design, conduct and recording of studies

clinical trials: prospectivley planned and appropriately controlled

30
Q

describe holoclars route to market authourisation

A
  • retrospective data was used from named patient treatments rather than performing a clinical trial with new patients. retrospective data is usually insufficient for regulatory approval
  • evidence from 119 treatments was provided from a long term efficacy and safety study and 29 from an observational study
  • the manufacturing process needed to be made compliant to GMP and converted to an industrial process to fit for commercial supply